Eisai
Mason C. Miranda is a seasoned IT leader specializing in research and development within the biotechnology sector. Currently serving as the Global R&D Discovery IT Lead at Eisai US since January 2020, Mason C. Miranda drives IT-business collaboration across international sites to enhance pre-clinical research in neurology and oncology. Prior roles include Head of Scientific Discovery IT at the Eisai Center for Genetics Guided Dementia Discovery and Director of Global R&D IT Solutions, where Mason C. Miranda developed technology solutions to support discovery capabilities. Previously, Mason C. Miranda held various positions at Harvard Medical School from February 2003 to January 2020, culminating in the role of Director of Research Information Technology Solutions, where responsibilities included leading technology transformations and managing IT services across multiple research departments. Mason C. Miranda is currently pursuing an ALB degree in Computer Science and Information Systems Management at Harvard University.
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.